Shanghai StairMed Technology Co., Ltd.

Shanghai StairMed Technology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://stairmed.com/

Last Round

Strategic

Apr 2, 2026

Total Funding Raised

$189.7M

Momentum Score

50 /100

Company Overview

Shanghai StairMed Technology Co., Ltd. is a therapeutic devices company that develops implantable brain-computer interface systems intended for motor control, neurological regulation, and sensory restoration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Clinical Trials, Industrial Robotics, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

brain-computer interfaceBCIneural implantbrain implantbrain chipneurotechnologyneurotechminimally invasive BCIinvasive BCIultra-flexible electrodesparalysis treatmentsurgical robotdeep brain stimulationDBSmedical devicesclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai StairMed Technology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanghai StairMed Technology Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 2, 2026
StrategicMar 13, 2026
Series BFeb 11, 2025
Series ADec 30, 2022
AngelDec 21, 2022

Shanghai StairMed Technology Co., Ltd. Investors

Notable investors and investment history

InvestorRounds
Yuanhe CapitalSeries A
FountainBridge CapitalStrategic, Series B, Angel
SDIC Unity CapitalStrategic
Lapam CapitalSeries B, Strategic
OrbiMedStrategic, Series B, Series A
上海国投先导私募基金管理有限公司Strategic
Source Code CapitalStrategic, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    $73M raised in a strategic round.

Shanghai StairMed Technology Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai StairMed Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai StairMed Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range5
Year Founded2021
Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.